Jefferies Financial Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,000
Closed -$1.51M 1562
2025
Q2
$1.51M Buy
+15,000
New +$1.15M 0.01% 606
2024
Q3
Sell
-7,500
Closed -$503K 1601
2024
Q2
$503K Buy
7,500
+2,200
+42% +$85.3K 0.01% 968
2024
Q1
$144K Buy
5,300
+2,200
+71% +$61.6K ﹤0.01% 1393
2023
Q4
$96.1K Buy
3,100
+100
+3% +$2.59K ﹤0.01% 1552
2023
Q3
$75.8K Buy
+3,000
New +$68.6K ﹤0.01% 1483

Other funds holding INSM

Jefferies Financial Group's INSM Position: Q2 2026 in Review

Jefferies Financial Group increased its Insmed (INSM) stake by 183% in Q2 2026, buying an estimated $774K and bringing the position to 9,896 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #945.

Jefferies Financial Group first reported a position in INSM in Q1 2023 and has held it in 13 quarters since. The position peaked at $161M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Jefferies Financial Group held 9,896 shares of Insmed worth $1.06M as of Q2 2026.
  • Jefferies Financial Group bought 6,396 Insmed shares in Q2 2026, an estimated $774K.
  • Insmed made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #945 holding.
  • Jefferies Financial Group first reported a position in Insmed in Q1 2023 and has held it in 13 quarters since.
  • Jefferies Financial Group's Insmed position peaked at $161M in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.